Share
 
Title
Code
Session Type
Track
Format
CME accreditation
ROOM/CHANNEL
Date Time
Moderator
10:30
2 min
Introduction
Anisa GHADRSHENAS, Unitaid-WHO, Switzerland
10:32
8 min
Is local production of HIV commodities a feasible strategy for improving domestic ownership and financial sustainability of HIV epidemiological control in low- and middle-income settings?
Frances ILIKA, Palladium- USAID Health Policy Plus, Nigeria
Abstract
10:40
8 min
Quantifying the health and economic impact of voluntary licensing of HIV medicines in low- and middle-income countries: putting numbers on additional uptake, deaths averted, and money saved by MPP licences
Sébastien MORIN, Medicines Patent Pool, Switzerland
Abstract
10:48
8 min
Estimated costs to address unmet financial needs for HIV pre-exposure prophylaxis, United States, 2018
Robert BONACCI, CDC, United States
Abstract
10:56
8 min
Thailand national PrEP program: moving towards sustainability
Cheewanan LERTPIRIYASUWAT, Ministry of Public Health, Thailand
Abstract
11:04
8 min
The economic returns of achieving the 2021-2030 AIDS targets to end the AIDS epidemic by 2030
Erik LAMONTAGNE, Unaids, Switzerland
Abstract
11:12
18 min
Q&A
Frances ILIKA, Palladium- USAID Health Policy Plus, Nigeria
Robert BONACCI, CDC, United States
Cheewanan LERTPIRIYASUWAT, Ministry of Public Health, Thailand
Erik LAMONTAGNE, Unaids, Switzerland
Sébastien MORIN, Medicines Patent Pool, Switzerland
Anisa GHADRSHENAS, Unitaid-WHO, Switzerland
AUTHOR
SUMMARY
HIGHLIGHTS
CRITICAL ASSESSMENT